UY27291A1 - IMMUNOCONJUGADOS OF CD44 TOXIC ANTIBODIES - Google Patents

IMMUNOCONJUGADOS OF CD44 TOXIC ANTIBODIES

Info

Publication number
UY27291A1
UY27291A1 UY27291A UY27291A UY27291A1 UY 27291 A1 UY27291 A1 UY 27291A1 UY 27291 A UY27291 A UY 27291A UY 27291 A UY27291 A UY 27291A UY 27291 A1 UY27291 A1 UY 27291A1
Authority
UY
Uruguay
Prior art keywords
immunoconjugados
toxic antibodies
relates
present
conjugates
Prior art date
Application number
UY27291A
Other languages
Spanish (es)
Inventor
Dr G Adolf
Dr E Patzelt
Dr M Sproll
Dr K-H Heider
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Priority to UY27291A priority Critical patent/UY27291A1/en
Publication of UY27291A1 publication Critical patent/UY27291A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a nuevos conjugados de anticuerpos con compuestos citotóxicos, a composiciones farmacéuticas que contienen dichos conjugados, y a su uso en la terapia del cáncer. En concreto, la presente invención se refiere a conjugados de anticuerpos que son específicos para cd44, con maitansinoides, preferiblemente con N2- desacetil-N2- (3-mercapto-1-oxopropil) maitansina.The present invention relates to new antibody conjugates with cytotoxic compounds, pharmaceutical compositions containing said conjugates, and their use in cancer therapy. Specifically, the present invention relates to antibody conjugates that are specific for cd44, with maitansinoids, preferably with N2-deacetyl-N2- (3-mercapto-1-oxopropyl) maitansin.

UY27291A 2002-05-15 2002-05-15 IMMUNOCONJUGADOS OF CD44 TOXIC ANTIBODIES UY27291A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27291A UY27291A1 (en) 2002-05-15 2002-05-15 IMMUNOCONJUGADOS OF CD44 TOXIC ANTIBODIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27291A UY27291A1 (en) 2002-05-15 2002-05-15 IMMUNOCONJUGADOS OF CD44 TOXIC ANTIBODIES

Publications (1)

Publication Number Publication Date
UY27291A1 true UY27291A1 (en) 2002-12-31

Family

ID=38812639

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27291A UY27291A1 (en) 2002-05-15 2002-05-15 IMMUNOCONJUGADOS OF CD44 TOXIC ANTIBODIES

Country Status (1)

Country Link
UY (1) UY27291A1 (en)

Similar Documents

Publication Publication Date Title
AR035977A1 (en) IMMUNOCONJUGADOS OF ANTIBODIES CD44 CITOTOXICOS.
UY27943A1 (en) COMPOSITIONS AND METHODS TO TREAT CRNCER USING ANTIBODY IMMUNOCATE PLAYS FOR CD44 CYTOTNXICS AND CHEMOTHERAPCUTIC AGENTS
NI200900022A (en) SPECIFIC ANTIBODY OF PRLR AND USES OF THE SAME
CL2009002199A1 (en) Antibody that specifically binds to crypto epitope; pharmaceutical composition comprising said antibody; use of the antibody to decrease the growth of a tumor in vitro; method to modulate the growth of tumor cells in vitro in a sample; humanized antibody (div. sol. No. 831-2002).
DE602006016344D1 (en) FOR THE FIBROBLAST ATTACHMENT PROTEIN SPECIFIC ANTIBODY MOLECULES AND IMMUNOCONJUGATES CONTAINING THEM
ATE472338T1 (en) ANTI-CD70 ANTIBODY DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
CY1117331T1 (en) ACCESSORIES IN ACCESSIBILITY 4 OUTSIDE AUTOMATIC CSF1R AND THEIR USE
ATE521366T1 (en) APPLICATION OF AMATOXIN CONJUGATES AND PHALLOTOXIN CONJUGATES WITH MACROMOLECLES FOR CANCER THERAPY AND THERAPY OF INFLAMMATION
AR069903A1 (en) ANTIBODY CONJUGATE - ASSOCIATED MOLECULA DIRECTED TO THE PROTEIN TIROSINA QUINASA 7 (PTK 7), PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, NUCLEIC ACID, EXPRESSION FACTOR AND RELATED HUMAN CELL AND ITS USE TO PREPARE A MEDICATION
EA200800952A1 (en) CONJUGATES ANTIBODY-DRUG AND METHODS OF APPLICATION
CR10273A (en) "ANTI-5T4 ANTIBODIES AND USES OF THE SAME"
AR069747A1 (en) ANTI-B7H4 MONOCLONAL ANTIBODY CONJUGATE - PHARMACO AND METHODS OF USE
BRPI0622073A8 (en) USE OF PDGFRALFA ANTIBODIES FOR MANUFACTURING A DRUG TO TREAT A BONE TUMOR
CY1113003T1 (en) LAQUINIMOD STABLE PREPARATIONS
CR9745A (en) ANTI-B7RP1 HUMAN NEUTRALIZING ANTIBODIES
MA30345B1 (en) ANTI-IGF-1R HUMAN MONOCLONAL ANTIBODY FORMULATION
CL2008003122A1 (en) Use of an anti-cd20 type II antibody useful to prepare a drug to treat a cancer that expresses cd20 in combination with a proteasome inhibitor, pharmaceutical composition containing said combination and kit of the same
BR112022011032A2 (en) ANTI-CLAUDIN ANTIBODY-DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF
EP2457928A3 (en) Monoclonal human tumor-specific antibody
MX2019008773A (en) Calicheamicin derivatives and antibody drug conjugates thereof.
SE0300457D0 (en) Novel compounds
AR046774A1 (en) LIOFILIZED FORMULATION OF ANTIBODY CONJUGATES
MX2023013995A (en) Anthracycline antibody conjugates.
UY27291A1 (en) IMMUNOCONJUGADOS OF CD44 TOXIC ANTIBODIES
PA8629401A1 (en) D-HOMO-17-CHLORINE-16 (17) ENO STEROIDS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150925